Nucleoside analogues alone or combined with vaccination prevent hepadnavirus viremia and induce protective immunity: Alternative strategy for hepatitis B virus post-exposure prophylaxis

Antiviral Research

Volumn 105, Issue 1, 2014, Pages 118-125

  Wang, Baoju ^a   Zhu, Zhenni ^a   Zhu, Bin ^a   Wang, Junzhong ^a   Song, Zhitao ^a   Huang, Shunmei ^a   Fan, Wei ^b   Tao, Yuanqing ^b   Wang, Zhongdong ^b   Wang, Hu ^b   Lu, Mengji ^a,c   Yang, Dongliang ^a  

^a UNION HOSPITAL   (China)

^b Qinghai Institute for Endemic Disease Prevention and Control   (China)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Chinese woodchuck; DNA vaccination; Hepatitis B virus post exposure prophylaxis; Marmota himalayana; Nucleotide analogue

Indexed keywords

DNA VACCINE; ENTECAVIR; PWHCIM VACCINE; UNCLASSIFIED DRUG; ENTACAVIR; NUCLEOSIDE ANALOG; ANTIVIRUS AGENT; GUANINE; VIRUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DNA IMMUNIZATION; HEPADNAVIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; IMMUNITY; INFECTION CONTROL; INFECTION PREVENTION; NONHUMAN; POST EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; VACCINATION; WOODCHUCK HEPATITIS; WOODCHUCK HEPATITIS VIRUS; COMBINATION CHEMOTHERAPY; INOCULATION; WOODCHUCK; ANALOGS AND DERIVATIVES; ANIMAL; DISEASE MODEL; DRUG COMBINATION; HEPADNAVIRIDAE INFECTIONS; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; TREATMENT OUTCOME; VIREMIA; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GUANINE; HEPADNAVIRIDAE INFECTIONS; HEPATITIS B VIRUS, WOODCHUCK; POST-EXPOSURE PROPHYLAXIS; TREATMENT OUTCOME; VACCINATION; VIRAL VACCINES; VIREMIA;

EID: 84897460567     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2014.02.016     Document Type: Article

References (38)

1. U.S. Public Health Service Updated U.S. Public Health Service guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis MMWR Recomm. Rep. 50 2001 1 52
2. S. Asabe, S.F. Wieland, P.K. Chattopadhyay, M. Roederer, R.E. Engle, R.H. Purcell, and F.V. Chisari The size of the viral inoculum contributes to the outcome of hepatitis B virus infection J. Virol. 83 2009 9652 9662
3. N.T. Bennett, and R.J. Howard Quantity of blood inoculated in a needlestick injury from suture needles J. Am. Coll. Surg. 178 1994 107 110 (Pubitemid 24073485)
4. D.M. Cardo, D.H. Culver, C.A. Ciesielski, P.U. Srivastava, R. Marcus, D. Abiteboul, J. Heptonstall, G. Ippolito, F. Lot, P.S. McKibben, and D.M. Bell A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group N. Engl. J. Med. 337 1997 1485 1490 (Pubitemid 27495773)
5. P.J. Cote, B.E. Korba, R.H. Miller, J.R. Jacob, B.H. Baldwin, W.E. Hornbuckle, R.H. Purcell, B.C. Tennant, and J.L. Gerin Effects of age and viral determinants on chronicity as an outcome of experimental woodchuck hepatitis virus infection Hepatology 31 2000 190 200 (Pubitemid 30033706)
6. H. Fan, Z. Zhu, Y. Wang, X. Zhang, Y. Lu, Y. Tao, W. Fan, Z. Wang, H. Wang, M. Roggendorf, M. Lu, B. Wang, and D. Yang Molecular characterization of the type I IFN receptor in two woodchuck species and detection of its expression in liver samples from woodchucks infected with woodchuck hepatitis virus (WHV) Cytokine 60 2012 179 185
7. F. Feng, C.Q. Teoh, Q. Qiao, D. Boyle, and A.R. Jilbert The development of persistent duck hepatitis B virus infection can be prevented using antiviral therapy combined with DNA or recombinant fowlpoxvirus vaccines Vaccine 28 2010 7436 7443
8. W.K. Foster, D.S. Miller, C.A. Scougall, I. Kotlarski, R.J. Colonno, and A.R. Jilbert Effect of antiviral treatment with entecavir on age- and dose-related outcomes of duck hepatitis B virus infection J. Virol. 79 2005 5819 5832 (Pubitemid 40548250)
9. H. Gatanaga, T. Hayashida, J. Tanuma, and S. Oka Prophylactic effect of antiretroviral therapy on hepatitis B virus infection Clin. Infect. Dis. 56 2013 1812 1819
10. E.V. Genovesi, L. Lamb, I. Medina, D. Taylor, M. Seifer, S. Innaimo, R.J. Colonno, D.N. Standring, and J.M. Clark Efficacy of the carbocyclic 2′-deoxyguanosine nucleoside BMS-200475 in the woodchuck model of hepatitis B virus infection Antimicrob. Agents Chemother. 42 1998 3209 3217 (Pubitemid 28553743)
11. S.A. Gujar, P.M. Mulrooney-Cousins, and T.I. Michalak Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis J. Virol. 87 2013 1035 1048
12. C.S. Guy, P.M. Mulrooney-Cousins, N.D. Churchill, and T.I. Michalak Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus J. Virol. 82 2008 8579 8591
13. A.P. Kourtis, M. Bulterys, D.J. Hu, and D.J. Jamieson HIV-HBV coinfection-a global challenge N. Engl. J. Med. 366 2012 1749 1752
14. D.R. Langley, A.W. Walsh, C.J. Baldick, B.J. Eggers, R.E. Rose, S.M. Levine, A.J. Kapur, R.J. Colonno, and D.J. Tenney Inhibition of hepatitis B virus polymerase by entecavir J. Virol. 81 2007 3992 4001 (Pubitemid 46586894)
15. X. Liang, S. Bi, W. Yang, L. Wang, G. Cui, F. Cui, Y. Zhang, J. Liu, X. Gong, Y. Chen, F. Wang, H. Zheng, F. Wang, J. Guo, Z. Jia, J. Ma, H. Wang, H. Luo, L. Li, S. Jin, S.C. Hadler, and Y. Wang Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China J. Infect. Dis. 200 2009 39 47
16. Y.F. Liaw, and C.M. Chu Hepatitis B virus infection Lancet 373 2009 582 592
17. F.M. Lu, and H. Zhuang Management of hepatitis B in China Chin. Med. J. (Engl.) 122 2009 3 4
18. M. Lu, and M. Roggendorf Evaluation of new approaches to prophylactic and therapeutic vaccinations against hepatitis B viruses in the woodchuck model Intervirology 44 2001 124 131 (Pubitemid 32757390)
19. M. Lu, G. Hilken, J. Kruppenbacher, T. Kemper, R. Schirmbeck, J. Reimann, and M. Roggendorf Immunization of woodchucks with plasmids expressing woodchuck hepatitis virus (WHV) core antigen and surface antigen suppresses WHV infection J. Virol. 73 1999 281 289 (Pubitemid 28565370)
20. M. Lu, M. Isogawa, Y. Xu, and G. Hilken Immunization with the gene expressing woodchuck hepatitis virus nucleocapsid protein fused to cytotoxic-T-lymphocyte-associated antigen 4 leads to enhanced specific immune responses in mice and woodchucks J. Virol. 79 2005 6368 6376 (Pubitemid 40617240)
21. Y. Lu, B. Wang, H. Huang, Y. Tian, J. Bao, J. Dong, M. Roggendorf, M. Lu, and D. Yang The interferon-alpha gene family of Marmota himalayana, a Chinese marmot species with susceptibility to woodchuck hepatitis virus infection Dev. Comp. Immunol. 32 2008 445 457 (Pubitemid 350296332)
22. S. Menne, and P.J. Cote The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection World J. Gastroenterol. 13 2007 104 124 (Pubitemid 46165467)
23. D.S. Miller, D. Boyle, F. Feng, G.Y. Reaiche, I. Kotlarski, R. Colonno, and A.R. Jilbert Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection Virology 373 2008 329 341
24. A.L. Panlilio, D.M. Cardo, L.A. Grohskopf, W. Heneine, and C.S. Ross Updated U.S. Public Health Service guidelines for the management of occupational exposures to HIV and recommendations for postexposure prophylaxis MMWR Recomm. Rep. 54 2005 1 17
25. M. Roggendorf, D. Yang, and M. Lu The woodchuck: a model for therapeutic vaccination against hepadnaviral infection Pathol. Biol. (Paris) 58 2010 308 314
26. S. Roos, K. Fuchs, and M. Roggendorf Protection of woodchucks from infection with woodchuck hepatitis virus by immunization with recombinant core protein J. Gen. Virol. 70 Pt 8 1989 2087 2095 (Pubitemid 19215112)
27. F. Schodel, G. Neckermann, D. Peterson, K. Fuchs, S. Fuller, H. Will, and M. Roggendorf Immunization with recombinant woodchuck hepatitis virus nucleocapsid antigen or hepatitis B virus nucleocapsid antigen protects woodchucks from woodchuck hepatitis virus infection Vaccine 11 1993 624 628 (Pubitemid 23142618)
28. W.H. Sheng, Y.C. Chuang, H.Y. Sun, M.S. Tsai, S.Y. Chang, C.C. Hung, and S.C. Chang Prophylactic effect of lamivudine-based antiretroviral therapy on incident hepatitis B virus infection among HIV-infected patients Clin. Infect. Dis. 57 2013 1504 1506
29. D.K. Smith, L.A. Grohskopf, R.J. Black, J.D. Auerbach, F. Veronese, K.A. Struble, L. Cheever, M. Johnson, L.A. Paxton, I.M. Onorato, and A.E. Greenberg Antiretroviral postexposure prophylaxis after sexual, injection-drug use, or other nonoccupational exposure to HIV in the United States: recommendations from the U.S. Department of Health and Human Services MMWR Recomm. Rep. 54 2005 1 20
30. S.J. Steppan, M.R. Akhverdyan, E.A. Lyapunova, D.G. Fraser, N.N. Vorontsov, R.S. Hoffmann, and M.J. Braun Molecular phylogeny of the marmots (Rodentia: Sciuridae): tests of evolutionary and biogeographic hypotheses Syst. Biol. 48 1999 715 734 (Pubitemid 129490560)
31. J. Summers, J.M. Smolec, and R. Snyder A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks Proc. Natl. Acad. Sci. USA 75 1978 4533 4537 (Pubitemid 9028391)
32. C.L. Thio Hepatitis B and human immunodeficiency virus coinfection Hepatology 49 2009 S138 S145
33. C.C. Tsai, K.E. Follis, A. Sabo, T.W. Beck, R.F. Grant, N. Bischofberger, R.E. Benveniste, and R. Black Prevention of SIV infection in macaques by (R)-9-(2-phosphonylmethoxypropyl)adenine Science 270 1995 1197 1199
34. B.J. Wang, Y.J. Tian, Z.J. Meng, M. Jiang, B.Q. Wei, Y.Q. Tao, W. Fan, A.Y. Li, J.J. Bao, X.Y. Li, Z.M. Zhang, Z.D. Wang, H. Wang, M. Roggendorf, M.J. Lu, and D.L. Yang Establishing a new animal model for hepadnaviral infection: susceptibility of Chinese Marmota-species to woodchuck hepatitis virus infection J. Gen. Virol. 92 2011 681 691
35. B.G. Werner, and G.F. Grady Accidental hepatitis-B-surface-antigen- positive inoculations. Use of e antigen to estimate infectivity Ann. Intern. Med. 97 1982 367 369 (Pubitemid 12061585)
36. A. Zerbini, M. Pilli, C. Boni, P. Fisicaro, A. Penna, P. Di Vincenzo, T. Giuberti, A. Orlandini, G. Raffa, T. Pollicino, G. Raimondo, C. Ferrari, and G. Missale The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection Gastroenterology 134 2008 1470 1481 (Pubitemid 351615362)
37. Zhu, D.; Wang, J.; Wangen, K. R. 2013. Hepatitis B vaccination coverage rates among adults in rural China: are economic barriers relevant? Vaccine (Epub ahead of print).
38. H. Ziglam, M. El-Hattab, N. Shingheer, A. Zorgani, and O. Elahmer Hepatitis B vaccination status among healthcare workers in a tertiary care hospital in Tripoli, Libya J. Infect. Public Health 6 2013 246 251